managing intellectual property - life sciences · 2017. 8. 2. · bank transfer quot ing reference...
TRANSCRIPT
-
LIFE SCIENCESF O R U M 2 0 1 7
S E P T E M B E R 2 0 1 7 , T H E W E S T I N , S A N D I E G O
6 CLEPOINTS
FREE FOR
IN-HOUSE COUNSEL
TO ATTEND
SUPPORTED BY
LMG Life Sciences
SPONSORED BY
WWW. M A N A G I N G I P. C O M
# L I F E S C I E N C E S 2 0 1 7
To register or for more information:
Luba Jersova: +44 (0) 207 779 8334
For in-house speaking opportunities:
+1 212 224 3417
For sponsorship opportunities:
+44 (0) 207 779 8836
-
LIFE SCIENCESF O R U M 2 0 1 7
SEPTEMBER 2017THE WESTIN,SAN DIEGO
INTRODUCTIONAs the Life Sciences industry continues to experience tumultuous changes through-out the years, IP owners in this sector continue to face unique opportunities andchallenges when protecting their patents. The changing political landscape,accompanied by rapid developments in drug discovery, research and pendingproposals in Congress, means that protecting your IP requires vigilance.
To appropriately address the major developments within the life sciences sector,the MIP Life Sciences Forum is returning to New York this September for the secondyear. Discussions will focus on strategies for patent drafting, and understandingdouble patents. The changing regulatory environment will also be examined, inaddition to what to expect from the latest patent prosecution trends and cases, andeven the changing patent landscape in Europe, to ensure IP counsel remain com-petitive in this rapidly growing market.
The programme addresses the major issues at hand and will encourage participa-tion and debate on all the pertinent topics within life sciences from varied perspec-tives. The MIP Life Sciences Forum 2016 brings together leaders in corporations,industry associations and leading legal experts to discuss and impart valuableknowledge.
Register your place today.
BENEFITS OFATTENDINGDelegates are invited to attend a fullday of debates and discussions tohear from, and network with, leadingexperts from multiple jurisdictions andindustries. All delegates will be partyto important debates about the mostsignificant developments in the lifesciences industry and will have theopportunity to contribute as well aslearn.
• Examine the latest developments inpatent prosecution and itsimplications on the life sciences
• Discuss key decisions andprecedents at PTAB over the past 12months
• Understand IP pricing through thelatest legislative developments
• Examine PTAB decision times andhow it is affecting your work load
• Listen to considerations to opt in orout of the Unitary Patent
• Join analysis on key trends inpharma litigation in the federalcircuit
WHO YOU WILLMEET• General counsel• In-house counsel• Head of IP• Patent counsel• Compliance officers• Corporate and legal affairs• Private practice• Judges
SPONSORSHIP OPPORTUNITIESSponsorship opportunities: We will create a bespoke solution that will position your organization as a thought leader andensure you engage with your target audience. This will help you to meet and influence the people who are going to growyour business. Please contact Melanie Petch on +44 20 7779 8836 or [email protected] to discuss.
-
LIFE SCIENCESF O R U M 2 0 1 7
SEPTEMBER 2017THE WESTIN,SAN DIEGO
PROGRAMMEOverview of patent prosecution developments & the impact on life sciences• Where is Congress now? Examining patent prosecution trends• Federal circuit decision: understanding double-patenting• The issue with infringement damages• Subject matter eligibility: amending 35 U.S.C. § 101
The financial risk of waiting: IP pricing in the modern age• Legislative developments: how is the dialogue within the industry changing?• New challenges of R&D effectiveness• List prices – understanding how intermediaries can play a more active role• Is the whack a mole method the most effective?
Patent Trial and Appeal Board: life sciences focus• Analysing PTAB statistics and best practices• Risks and remedies of litigating at the PTAB• Key decisions and precedents over the past 12 months• Pharma IPRs: how to make your company IPR ready
Taking action in an uncertain regulatory environment• Maintaining business models under the current tumultuous environment• The implementation of the IDMP• Regulatory updates for medical devises: the FDA & cybersecurity• Quality metrics: how new guidance can change inspection protocol
The intersection between PTAB decision times and innovation• PTAB decision time and its effect on your work load• Debate: what should researchers be doing?• To what extent are PTAB decision times stifling innovation?• Strategies to ensure the procurement process go more swiftly and successfully
Abbreviated New Drug Applications (ANDA) cases and IPRs• Identifying how can they work in tandem with each other• When to file: how timing strategies have evolved• Is new research affecting application strategies?• New updates from the FDA
Looking to the future of pharma branding: key issues and possible solutions• Synchronizing your brand in today's competitive healthcare marketplace• Identifying the most efficient processes to successfully obtain trademark protection
and FDA approval• Appreciating the pros and cons of technology• Case study: tracking the emerging threats for global companies
Unified Patent Court & Unitary Patent: to opt or not to opt• Final preparations for the sunrise period• Taking steps towards ‘troll proofing’ your business• Alignment of UK courts and other national patent courts within the EU• Future forecast: will the UK remain in the system post-Brexit?
Pharma litigation: key developments over the past 12 months• Overcoming the uncertainty of US pharma litigation• Tracking crucial Federal Circuit decisions• Inside relief post-e-Bay
-
LIFE SCIENCESF O R U M 2 0 1 7
SEPTEMBER 2017THE WESTIN,SAN DIEGO
Booking fee Private practice andadvisers
In-house/IP counsel, headsof legal and R&Dprofessionals
Early booking rate (before , July 14)
$695 FREE
Standard booking rate (after , July 14)
$995 FREE
Payment must be received before the conference date to guarantee your place.Please tick box to select payment method and sign agreement in box
Bank transfer quoting reference number£ Account – 01043191; Sort code – 30-00-02IBAN no – GB 97 LOYD 300002 01043191Lloyds Bank TSB Plc, City Office, PO Box 72, Bailey Drive,Gillingham Business Park, Gillingham, Kent, ME8 0LS, UK$ Account – 11512129; Sort code – 30-12-18IBAN no – GB 29 LOYD 301218 11512129€ Account – 59008833; Sort code – 30-12-18IBAN no – GB 25 LOYD 301218 59008833SWIFT address: LOYD GB2 LCTY
To make a payment by credit card, please register and pay online at:www.managingip.com or call +44 (0) 20 7779 8334
Please note that in completing this booking form you undertake to adhere to the cancellation andpayment terms listed below.
Signature: Date:
Position:
Delegate 1
Name:
Job title:
Company:
Address:
Postcode:
Country:
Tel:
Email:
Delegate 2
Name:
Job title:
Company:
Address:
Postcode:
Country:
Tel:
Email:
1|Register (Please tick one box)
Please find chequeenclosed (please makepayable to EuromoneyTrading Ltd)
2|Your details for registration (Please print)
I cannot attend but please add me to your mailing list for future events.
3|Method of payment
Onlinewww.managingip.com
Telephone+44 (0) 20 7779 8334
MailLuba Jersova
Legal Media Group8 Bouverie Street
London, EC4Y 8AX, UK
CANCELLATION POLICY: If you cannot attend you mustcancel your registration in writing by 18 August 2017 toreceive a refund less a 10% administration charge.Cancellations received after 18 August 2017, or noshows, are liable for the full conference fee (where appli-cable). You may send a substitute to attend in your placeat no extra charge, however we must know by 8September 2017 via email. We cannot accept verbalcancellations. If you make your booking online, by emailor via the telephone, you are automatically adhering toour terms and conditions.
REGISTRATION FEE: The registration fee includes partici-pation in the forum, documentation material, breakfast,coffee breaks and lunch. All delegates are responsible fortheir own accommodation and travel.
PAYMENT: All registration fees (where applicable) must bereceived in full prior to the event date.
The information you provide on this form will be used byEuromoney Institutional Investor PLC and its group compa-nies (“we” or “us”) to process your order and deliver therelevant products/services. We may also monitor youruse of the website(s) relating to your order, includinginformation you post and actions you take, to improveour services and track compliance with our terms of use.Except to the extent you indicate your objection below,we may also use your data (including data obtained frommonitoring) (a) to keep you informed of our products andservices; (b) occasionally to allow companies outside ourgroup to contact you with details of their products/ser-vices; or (c) for our journalists to contact you for researchpurposes. As an international group, we may transferyour data on a global basis for the purposes indicatedabove, including to countries which may not provide thesame level of protection to personal data as within theEuropean Union. By submitting this order, you will beindicating your consent to the use of your data as identi-fied above. Further detail on our use of your personaldata is set out in our privacy policy, which is available atwww.euromoneyplc.com or can be provided to you sepa-rately upon request.If you object to contact by telephone , fax , or email, or post , please tick the relevant box. If you do notwant us to share your information with our journalists ,or other companies please tick the relevant box.
To Register